DK0515265T3 - Pyrimidinderivater, fremgangsmåde til deres fremstilling, opnåede hidtil ukendte mellemprodukter, deres anvendelse som lægemidler og farmaceutiske præparater med indhold deraf - Google Patents
Pyrimidinderivater, fremgangsmåde til deres fremstilling, opnåede hidtil ukendte mellemprodukter, deres anvendelse som lægemidler og farmaceutiske præparater med indhold derafInfo
- Publication number
- DK0515265T3 DK0515265T3 DK92401363.4T DK92401363T DK0515265T3 DK 0515265 T3 DK0515265 T3 DK 0515265T3 DK 92401363 T DK92401363 T DK 92401363T DK 0515265 T3 DK0515265 T3 DK 0515265T3
- Authority
- DK
- Denmark
- Prior art keywords
- aryl
- alkyl
- alkenyl
- alkoxy
- hydroxyl
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D239/00—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings
- C07D239/02—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings
- C07D239/24—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members
- C07D239/26—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to ring carbon atoms
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/12—Antihypertensives
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D239/00—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings
- C07D239/02—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings
- C07D239/24—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members
- C07D239/28—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, directly attached to ring carbon atoms
- C07D239/32—One oxygen, sulfur or nitrogen atom
- C07D239/34—One oxygen atom
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D239/00—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings
- C07D239/02—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings
- C07D239/24—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members
- C07D239/28—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, directly attached to ring carbon atoms
- C07D239/46—Two or more oxygen, sulphur or nitrogen atoms
- C07D239/52—Two oxygen atoms
- C07D239/54—Two oxygen atoms as doubly bound oxygen atoms or as unsubstituted hydroxy radicals
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D403/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00
- C07D403/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings
- C07D403/10—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings linked by a carbon chain containing aromatic rings
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D417/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00
- C07D417/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings
- C07D417/10—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings linked by a carbon chain containing aromatic rings
Landscapes
- Organic Chemistry (AREA)
- Chemical & Material Sciences (AREA)
- Health & Medical Sciences (AREA)
- Veterinary Medicine (AREA)
- Engineering & Computer Science (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Pharmacology & Pharmacy (AREA)
- Public Health (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Cardiology (AREA)
- Heart & Thoracic Surgery (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Plural Heterocyclic Compounds (AREA)
- Nitrogen Condensed Heterocyclic Rings (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
FR9106203A FR2676734B1 (fr) | 1991-05-23 | 1991-05-23 | Nouveaux derives de la pyrimidine, leur procede de preparation, les nouveaux intermediaires obtenus, leur application a titre de medicaments et les compositions pharmaceutiques les renfermant. |
Publications (1)
Publication Number | Publication Date |
---|---|
DK0515265T3 true DK0515265T3 (da) | 1997-10-20 |
Family
ID=9413040
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
DK92401363.4T DK0515265T3 (da) | 1991-05-23 | 1992-05-20 | Pyrimidinderivater, fremgangsmåde til deres fremstilling, opnåede hidtil ukendte mellemprodukter, deres anvendelse som lægemidler og farmaceutiske præparater med indhold deraf |
Country Status (10)
Country | Link |
---|---|
US (1) | US5474996A (da) |
EP (1) | EP0515265B1 (da) |
JP (1) | JP3182213B2 (da) |
AT (1) | ATE151756T1 (da) |
CA (1) | CA2069261A1 (da) |
DE (1) | DE69219008T2 (da) |
DK (1) | DK0515265T3 (da) |
ES (1) | ES2100314T3 (da) |
FR (1) | FR2676734B1 (da) |
GR (1) | GR3023295T3 (da) |
Families Citing this family (24)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
GB9314355D0 (en) * | 1993-07-12 | 1993-08-25 | Sandoz Ltd | Novel compounds |
GB9519787D0 (en) * | 1995-09-28 | 1995-11-29 | Sandoz Ltd | Organic compounds |
KR100239800B1 (ko) * | 1996-11-28 | 2000-03-02 | 손경식 | 4,5-디아미노 피리미딘 유도체 및 이의 제조방법 |
FR2781219B1 (fr) * | 1998-07-16 | 2000-08-25 | Synthelabo | Procede pour la preparation de 5-(1-methylethyl)-6-(phenylmethyl)pyrimidine-2,4 (1h, 3h) -dione |
US6455734B1 (en) | 2000-08-09 | 2002-09-24 | Magnesium Diagnostics, Inc. | Antagonists of the magnesium binding defect as therapeutic agents and methods for treatment of abnormal physiological states |
SE9903028D0 (sv) | 1999-08-27 | 1999-08-27 | Astra Ab | New use |
MXPA03003612A (es) | 2000-10-23 | 2003-06-19 | Smithkline Beecham Corp | Compuestos novedosos. |
US20030225075A1 (en) * | 2002-04-10 | 2003-12-04 | Orchid Chemicals & Pharmaceuticals Limited | Novel pyrimidone derivatives |
TWI287010B (en) | 2003-06-12 | 2007-09-21 | Euro Celtique Sa | Therapeutic agents useful for treating pain |
PE20100737A1 (es) | 2005-03-25 | 2010-11-27 | Glaxo Group Ltd | Nuevos compuestos |
EP1896476A2 (en) * | 2005-06-28 | 2008-03-12 | Orchid Research Laboratories Limited | Novel pyrazolopyrimidinone derivatives |
JP5372913B2 (ja) * | 2007-04-27 | 2013-12-18 | パーデュー、ファーマ、リミテッド、パートナーシップ | 疼痛治療に有効な治療薬 |
EP2527360B1 (en) | 2007-06-04 | 2015-10-28 | Synergy Pharmaceuticals Inc. | Agonists of guanylate cyclase useful for the treatment of gastrointestinal disorders, inflammation, cancer and other disorders |
US8969514B2 (en) | 2007-06-04 | 2015-03-03 | Synergy Pharmaceuticals, Inc. | Agonists of guanylate cyclase useful for the treatment of hypercholesterolemia, atherosclerosis, coronary heart disease, gallstone, obesity and other cardiovascular diseases |
US20100120694A1 (en) | 2008-06-04 | 2010-05-13 | Synergy Pharmaceuticals, Inc. | Agonists of Guanylate Cyclase Useful for the Treatment of Gastrointestinal Disorders, Inflammation, Cancer and Other Disorders |
ES2624828T3 (es) | 2008-07-16 | 2017-07-17 | Synergy Pharmaceuticals Inc. | Agonistas de la guanilato ciclasa útiles para el tratamiento de trastornos gastrointestinales, inflamación, cáncer y otros |
GB0908394D0 (en) | 2009-05-15 | 2009-06-24 | Univ Leuven Kath | Novel viral replication inhibitors |
GB0913636D0 (en) * | 2009-08-05 | 2009-09-16 | Univ Leuven Kath | Novel viral replication inhibitors |
US8536087B2 (en) | 2010-04-08 | 2013-09-17 | International Imaging Materials, Inc. | Thermographic imaging element |
US9616097B2 (en) | 2010-09-15 | 2017-04-11 | Synergy Pharmaceuticals, Inc. | Formulations of guanylate cyclase C agonists and methods of use |
AU2011331301A1 (en) | 2010-11-15 | 2013-05-23 | Katholieke Universiteit Leuven | Antiviral condensed heterocyclic compounds |
WO2014151206A1 (en) | 2013-03-15 | 2014-09-25 | Synergy Pharmaceuticals Inc. | Agonists of guanylate cyclase and their uses |
WO2014151200A2 (en) | 2013-03-15 | 2014-09-25 | Synergy Pharmaceuticals Inc. | Compositions useful for the treatment of gastrointestinal disorders |
US10011637B2 (en) | 2013-06-05 | 2018-07-03 | Synergy Pharmaceuticals, Inc. | Ultra-pure agonists of guanylate cyclase C, method of making and using same |
Family Cites Families (9)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
DE3609596A1 (de) * | 1986-03-21 | 1987-10-01 | Hoechst Ag | 2-azolylmethyl-2-aryl-1,3-dioxolane und deren salze, verfahren zu ihrer herstellung, sie enthaltende mittel und ihre verwendung |
US4935516A (en) * | 1988-01-29 | 1990-06-19 | Ube Industries, Ltd. | Process for preparing 4-hydroxypyrimidine |
DK160270C (da) * | 1988-12-16 | 1991-08-05 | Cheminova Agro As | Fremgangsmaade til fremstilling af 2,4- eller 2,4,5-substituerede 6-hydroxypyrimidiner |
EP0407342A3 (en) * | 1989-07-06 | 1991-07-10 | Ciba-Geigy Ag | Pyrimidine derivatives |
GB8917222D0 (en) * | 1989-07-27 | 1989-09-13 | Schering Agrochemicals Ltd | Herbicides |
US5100897A (en) * | 1989-08-28 | 1992-03-31 | Merck & Co., Inc. | Substituted pyrimidinones as angiotensin ii antagonists |
EP0435827A3 (en) * | 1989-12-28 | 1991-11-13 | Ciba-Geigy Ag | Diaza compounds |
CA2053148A1 (en) * | 1990-10-16 | 1992-04-17 | Karnail Atwal | Dihydropyrimidine derivatives |
DE4039630A1 (de) * | 1990-12-12 | 1992-06-17 | Bayer Ag | Substituierte pyrimidylamidoxime |
-
1991
- 1991-05-23 FR FR9106203A patent/FR2676734B1/fr not_active Expired - Fee Related
-
1992
- 1992-05-20 EP EP92401363A patent/EP0515265B1/fr not_active Expired - Lifetime
- 1992-05-20 ES ES92401363T patent/ES2100314T3/es not_active Expired - Lifetime
- 1992-05-20 DE DE69219008T patent/DE69219008T2/de not_active Expired - Fee Related
- 1992-05-20 AT AT92401363T patent/ATE151756T1/de not_active IP Right Cessation
- 1992-05-20 DK DK92401363.4T patent/DK0515265T3/da active
- 1992-05-22 CA CA002069261A patent/CA2069261A1/fr not_active Abandoned
- 1992-05-22 US US07/888,750 patent/US5474996A/en not_active Expired - Lifetime
- 1992-05-22 JP JP15426092A patent/JP3182213B2/ja not_active Expired - Fee Related
-
1997
- 1997-04-30 GR GR960403065T patent/GR3023295T3/el unknown
Also Published As
Publication number | Publication date |
---|---|
GR3023295T3 (en) | 1997-07-30 |
DE69219008T2 (de) | 1997-11-06 |
ATE151756T1 (de) | 1997-05-15 |
FR2676734B1 (fr) | 1995-05-19 |
DE69219008D1 (de) | 1997-05-22 |
FR2676734A1 (fr) | 1992-11-27 |
JP3182213B2 (ja) | 2001-07-03 |
JPH05178840A (ja) | 1993-07-20 |
EP0515265B1 (fr) | 1997-04-16 |
ES2100314T3 (es) | 1997-06-16 |
EP0515265A1 (fr) | 1992-11-25 |
US5474996A (en) | 1995-12-12 |
CA2069261A1 (fr) | 1992-11-24 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
DK0515265T3 (da) | Pyrimidinderivater, fremgangsmåde til deres fremstilling, opnåede hidtil ukendte mellemprodukter, deres anvendelse som lægemidler og farmaceutiske præparater med indhold deraf | |
DK0498723T3 (da) | Dobbeltcykliske nitrogenforbindelser, fremgangsmåde til deres fremstilling, deres anvendelse som lægemidler samt farmaceutiske præparater med indhold deraf | |
DK0498722T3 (da) | Nye bicycliske nitrogenforbindelser substitueret med en benzylgruppe, fremgangsmåde til deres fremstilling, de opnåede nye intermediærer, deres anvendelse som lægemidler og de pharmaceutiske præparater som de indgår i | |
DK0834508T3 (da) | Substituerede biphenyl- eller phenylpyridinderivater, fremgangsmåde til fremstilling heraf og farmaceutiske sammensætninger indeholdende disse | |
CY1112331T1 (el) | Παραγωγα πυριμιδινης που αναστελλουν τον hiv | |
CO5700776A2 (es) | Compuestos utiles para el tratamiento de enfermedades | |
MX9100092A (es) | Nuevos derivados sulfurados de imidazol,procedimiento para su preparacion,nuevos compuestos intermedios obtenidos y composiciones farmaceuticas que los contienen | |
DK0498721T3 (da) | Nye N-substituerede quinolinforbindelser, fremgangsmåde til deres fremstilling, mellemprodukter deraf, deres anvendelse som | |
AP1475A (en) | Trisubstituted 1, 3, 5-triazine derivatives for treatment of HIV infections. | |
BR0307833A (pt) | Sìntese controlada de ziprasidona e suas composições | |
DK0574545T3 (da) | Phenylamidinderivater som blodpladeaggregationsinhibitorer | |
DK0773943T3 (da) | Forbindelser, der er anvendelige som antiproliferative midler og garft-inhibitorer | |
MXPA05008584A (es) | Compuestos heterociclicos utiles como activadores de nurr-1. | |
DK0657422T3 (da) | Naphthyloxyeddikesyrederivater som PEG2-agonister og -antagonister | |
AR007088A1 (es) | 2,4-diaminopirimidinas sustituidas, compuestos intermedios utilizados en su preparacion, procedimiento para la preparacion de dichas 2,4-diaminopirimidinas sustituidas, medicamentos que las contienen y empleos de dichas pirimidinas | |
DE69911557D1 (de) | Imidazoline Derivate,ihre Herstellung und pharmazeutische Zusammensetzungen die sie enthalten | |
NO961456L (no) | Nye tricykliske amider, fremgangsmåter ved deres fremstilling og farmasöytiske sammensetninger som inneholder dem | |
WO2002079183A8 (en) | Halogenated rhodamine derivatives and applications thereof | |
AR018869A1 (es) | Composicion farmaceutica, su uso para la preparacion de medicamentos y estuche que la contiene | |
CA2410273A1 (en) | Halogenated rhodamine derivatives and applications thereof | |
UY27568A1 (es) | Forma de fármaco cristalina | |
AR034287A1 (es) | Compuestos azepan , procedimiento para su preparacion y composiciones farmaceuticas que los contienen | |
FI970424A0 (fi) | Imidatsolin uusi käyttö ja uusia johdannaisia, menetelmä niiden valmistamiseksi, näin saatuja uusia välituotteita, niiden uusia lääketieteellisiä käyttösovelluksia ja niitä sisältäviä farmaseuttisia koostumuksia | |
NO970350D0 (no) | Forbindelser anvendelige som anti-formeringsmidler og GARFT-inhibitorer | |
CY1109966T1 (el) | Υποκατεστημενα αραλκυλοπαραγωγα |